Ulrika Segersten
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
-
- Vitamin D Research Studies
Papers in
- Surgery 20
- Bladder and Urothelial Cancer Treatments 19
- Urinary and Genital Oncology Studies 4
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Per‐Uno Malmström (26 shared papers)Per Hellman (6 shared papers)Gunnar Westin (6 shared papers)Göran Åkerström (4 shared papers)Pamela Correa (2 shared papers)Lars Dyrskjøt (8 shared papers)Torben F. Ørntoft (6 shared papers)Sara Bergström Lind (5 shared papers)
In The Last Decade
Ulrika Segersten
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Nephrology 123
- Pathology and Forensic Medicine 238
- Cancer Research 162
- Surgery 403
- Orthopedics and Sports Medicine 58
Countries citing papers authored by Ulrika Segersten
This map shows the geographic impact of Ulrika Segersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Segersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Segersten more than expected).
Fields of papers citing papers by Ulrika Segersten
This network shows the impact of papers produced by Ulrika Segersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Segersten. The network helps show where Ulrika Segersten may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrika Segersten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 138 | |
| 2 | 2016 | 113 | |
| 3 | 2011 | 82 | |
| 4 | 2009 | 81 | |
| 5 | 2012 | 69 | |
| 6 | 2012 | 67 | |
| 7 | 2009 | 57 | |
| 8 | 2005 | 54 | |
| 9 | 2014 | 45 | |
| 10 | 2020 | 45 | |
| 11 | 2013 | 45 | |
| 12 | An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer. | 2011 | 44 |
| 13 | 2002 | 43 | |
| 14 | 2002 | 40 | |
| 15 | 2013 | 39 | |
| 16 | 2005 | 33 | |
| 17 | 2014 | 33 | |
| 18 | 2013 | 33 | |
| 19 | 2012 | 27 | |
| 20 | 2017 | 20 |
About Ulrika Segersten
Ulrika Segersten is a scholar working on Surgery, Molecular Biology, Nephrology, Pathology and Forensic Medicine and Cancer Research, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (19 papers), Vitamin D Research Studies (6 papers), Parathyroid Disorders and Treatments (5 papers), Cancer, Lipids, and Metabolism (4 papers), Urinary and Genital Oncology Studies (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Epigenetics and DNA Methylation (3 papers) and Urological Disorders and Treatments (2 papers). The work is most often cited by research in Nephrology (123 citations), Pathology and Forensic Medicine (238 citations), Cancer Research (162 citations), Surgery (403 citations) and Orthopedics and Sports Medicine (58 citations). Ulrika Segersten has collaborated with scholars based in Sweden, Denmark and Spain. Frequent co-authors include Per‐Uno Malmström, Per Hellman, Gunnar Westin, Göran Åkerström, Pamela Correa, Lars Dyrskjøt, Torben F. Ørntoft, Sara Bergström Lind, Kenneth Wester and Tobias Carling. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer, Scientific Reports, American Journal Of Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.